Global Automation in Biopharma Industry Markets, Trends, Opportunity, & Forecast 2018-2028: Significant Spending by Biopharma Companies, Research Institutions Drives Market Growth

News provided by

Feb 27, 2024, 19:45 ET

DUBLIN, Feb. 27, 2024 /PRNewswire/ -- The "Automation in Biopharma Industry Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ResearchAndMarkets.com's offering.

The Global Automation in Biopharma Industry Market was valued at USD 1775.20 million in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.80% through 2028, reaching USD 2468.19 million.

Lab automation systems enable high-throughput screening of compounds, allowing researchers to quickly test many potential drug candidates. This is essential in the early stages of drug discovery. Automation systems in the lab provide precise and accurate handling of samples, reducing the risk of human error and ensuring consistent and reliable results. Automation simplifies data collection, storage, and analysis. It enables real-time monitoring and data processing, facilitating faster decision-making in research and development.

Automated processes are more efficient and can run continuously, reducing the time and effort required for experiments and assays. This accelerates research and development timelines. Automation reduces the need for manual labor in repetitive and time-consuming tasks, resulting in cost savings and the redeployment of human resources to more strategic activities. Automation optimizes the use of resources, such as reagents, consumables, and equipment, making laboratory operations more cost-effective.

In biopharmaceutical manufacturing, process automation is crucial. It involves the use of automated systems and instruments for tasks such as cell culture, fermentation, purification, and fill-finish operations. Process automation ensures the precise control of critical parameters (e.g., temperature, pH, and agitation) to maintain product quality and consistency. Robotic systems are employed for a wide range of tasks, from drug discovery and sample handling to filling and packaging in manufacturing. Robots can be programmed to handle samples, reagents, and labware, performing tasks with precision and repeatability.

Automation systems provide advanced quality control and assurance in biopharma manufacturing. They monitor and control critical parameters and offer real-time feedback to ensure that products meet stringent quality standards. The biopharma industry is subject to rigorous quality and safety regulations. Automation systems aid in compliance by providing accurate data, traceability, and documentation, which are crucial for regulatory approval.

Ongoing technological innovations in automation, such as the use of artificial intelligence, machine learning, and robotics, are driving the adoption of cutting-edge systems for research and production. Biopharmaceutical products are becoming more complex, requiring advanced automation to produce biologics, cell therapies, and gene therapies.

The North America region dominates the Global Automation in Biopharma Industry Market in 2022. North America, particularly the United States, is home to a significant number of leading biopharmaceutical companies, research institutions, and academic centers. These organizations invest heavily in automation to improve their research, development, and manufacturing processes. The region has a well-developed technological infrastructure and a strong industrial base, making it easier for companies to adopt and integrate automation solutions.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automation in Biopharma Industry Market.

PerkinElmer, Inc.
AMETEK, Inc.
Autodesk, Inc.
Baumueller-Nuermont Corp
Emerson Electric Co.
Kawasaki Robotics
RheoSense Inc.
Rockwell Automation, Inc.
Sartorius Stedim Biotech SA
Siemens Healthineers

Report Scope

Automation in Biopharma Industry Market, By Technology:

Automation Technology
Digitization Technology

Automation in Biopharma Industry Market, By Application:

Clinical Phase
Drug Discovery Phase
Production Phase

Automation in Biopharma Industry Market, By Component:

Automation Hardware
Automation Software
Services Project Phase
Services Operation Phase

Automation in Biopharma Industry Market, By region:

North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

For more information about this report visit https://www.researchandmarkets.com/r/51d6ei

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets